$41.38 $0.11 per serving
Product analysis
CoQ10 100 mg may support some measures of heart and blood-vessel health in selected adults, although results are mixed. Its single-ingredient approach offers good value for someone specifically seeking CoQ10.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality40
CoQ10 is identified as ubiquinone, so its preparation is clear. That name alone does not establish better absorption than other CoQ10 options.
Ingredient Transparency100
The CoQ10 amount and preparation are both disclosed. That makes serving comparisons straightforward.
Value For Money100
The CoQ10 serving offers good value for its declared preparation and amount. That supports an affordable single-ingredient approach.
Customer Satisfaction95
Customer feedback is very positive across a large number of ratings. Those opinions do not establish effectiveness or safety.
Product Focus70
The single ingredient mainly fits heart support and normal energy production in cells. Evidence for everyday fatigue relief and wider health effects is more limited.
- Format
Capsule - Container
- 360 Capsule(s)
- Per serving
- $0.11
- Also available
CoQ10 100 mg$15.07- Customer rating
- 4.8 · 74,646 ratings
Goals
Impact
Moderate effect
Coenzyme Q-10 · 100 mg
CoQ10 at 100 mg supports mitochondrial energy production and antioxidant processes. The supplied human evidence concerns selected skin changes with a particular water-soluble preparation, so wider healthy-aging benefits remain uncertain for generic CoQ10.
How this product is rated for Longevity
Ingredient fit73
The relevant ingredients are a clear focus of the formula. The assessed amounts partly meet the saved comparison benchmarks.
Goal fit
The relevant ingredients are a clear focus of the formula.
Dose adequacy
The assessed amounts partly meet the saved comparison benchmarks.
Pathways10
The strongest assessed area is mitochondrial energy production, with limited coverage. No assessed area reaches the threshold for substantial coverage.
Depth
The strongest assessed area is mitochondrial energy production, with limited coverage.
Breadth
No assessed area reaches the threshold for substantial coverage.
Evidence30
Coenzyme Q-10 provides the strongest evidence contribution among the assessed ingredients, with important limits on broader healthy-aging claims. The assessed ingredients do not match the recognized trial preparations.
Evidence strength
Coenzyme Q-10 provides the strongest evidence contribution among the assessed ingredients, with important limits on broader healthy-aging claims.
Studied preparation
The assessed ingredients do not match the recognized trial preparations.
Formulation logic100
The assessed ingredients can contribute independently or have their required partner. No configured ingredient conflict was matched in the supplied assessment. All ingredients included in this check reach its minimum amount threshold.
Partner coverage
The assessed ingredients can contribute independently or have their required partner.
Conflicts
No configured ingredient conflict was matched in the supplied assessment.
Effective doses
All ingredients included in this check reach its minimum amount threshold.
Impact
Highest effect
Coenzyme Q-10 · 100 mg
Coenzyme Q-10 has limited support for blood-pressure, lipid and blood-vessel function markers in people with dyslipidemia. This product declares ubiquinone, which fits the general CoQ10 preparation rather than the separately studied ubiquinol form. Its amount can be compared with the reviewed 120 mg daily study exposure, but that comparison does not establish cardiovascular-event prevention or a superior delivery form.
How this product is rated for Cardiovascular Support
Ingredient fit86
The formula is focused on CoQ10 without other counted off-goal actives.
Goal fit
The formula is focused on CoQ10 without other counted off-goal actives.
Dose adequacy
The 100 mg CoQ10 serving is below the reviewed 120 mg daily study exposure.
Pathways53
The saved finding is concentrated in blood-vessel nitric-oxide function.
Depth
The saved finding is concentrated in blood-vessel nitric-oxide function.
Breadth
Only this area reaches the saved coverage reference; the other evaluated areas have no contribution.
Evidence88
CoQ10 leads through limited marker findings in dyslipidemia rather than proven cardiovascular-event prevention.
Evidence strength
CoQ10 leads through limited marker findings in dyslipidemia rather than proven cardiovascular-event prevention.
Studied preparation
The counted preparation satisfies the saved preparation check; this does not extend the supplied findings to other populations or outcomes.
Formulation logic100
The counted ingredients satisfy the partner and amount checks, with no matched configured conflict.
Partner coverage
The counted ingredients were treated as working alone or having their required partners.
Conflicts
The stimulant and high-sodium adjustments are inapplicable because the required ingredients are absent.
Effective doses
All counted ingredients meet the saved amount threshold; that threshold is not proof of clinical effectiveness.
Impact
Highest effect
Coenzyme Q-10 · 100 mg
Coenzyme Q10 may contribute to blood-pressure, lipid and blood-vessel measures in selected adults, although study results are mixed. Its 100 mg per serving falls below the conventional exposure used as the main comparison.
How this product is rated for Heart Health
Ingredient fit86
The declared active ingredients are focused on the heart-related roles included here. The relevant declared amounts provide substantial but incomplete coverage of the saved exposure comparison.
Goal fit
The declared active ingredients are focused on the heart-related roles included here.
Dose adequacy
The relevant declared amounts provide substantial but incomplete coverage of the saved exposure comparison.
Pathways53
The strongest saved connection is to blood-vessel function. Coverage across other heart-related roles is limited.
Depth
The strongest saved connection is to blood-vessel function.
Breadth
The broader saved findings cover blood-vessel function. .
Evidence98
Coenzyme Q-10 leads the saved evidence finding. Accepted preparation matches do not remove the ingredient-specific limitations described above.
Evidence strength
Coenzyme Q-10 provides the leading evidence contribution in the saved comparison; its clinical limitations still apply.
Studied preparation
The saved finding accepts the preparations used for its included ingredients; it does not establish that every labelled preparation matches a clinical trial.
Formulation logic100
The saved checks find no missing required partner or configured conflict. The included amounts pass the minimum comparison screen.
Partner coverage
The included ingredients do not lack a required partner under the saved finding; this does not establish added benefit from combining them.
Conflicts
No configured ingredient conflict was triggered by the supplied facts.
Effective doses
All ingredients included in this amount screen meet its minimum comparison level; that level is not a proven effective dose.
Impact
High effect
Coenzyme Q-10 · 100 mg
Coenzyme Q10 as ubiquinone has a limited, preparation-specific connection to fatigue relief and participates in mitochondrial energy production. The 100 mg per serving receives a partial amount contribution in the saved findings. This does not establish routine increased vitality in healthy adults or transfer results from clinical disease populations.
How this product is rated for Energy
Ingredient fit73
Ubiquinone is identified, with a partial contribution from its declared amount.
Goal fit
The relevant ingredients account for the formula's main connection to energy, although it also has broader uses.
Dose adequacy
The declared amounts receive a partial overall contribution, with some amounts contributing more than others.
Pathways17
The represented routes reflect the ingredients' saved findings, with limited coverage beyond the strongest route.
Depth
The main represented route is mitochondrial energy production, with the extent limited to the supplied findings.
Breadth
None of the listed routes reaches the comparison's coverage threshold.
Evidence84
Ubiquinone has limited preparation-specific fatigue evidence, with clinical results not automatically applying to routine healthy use.
Evidence strength
Coenzyme Q-10 supplies the strongest supported contribution here; its practical benefit remains limited to the relevant use and population.
Studied preparation
The contributing preparations are treated as studied in the saved findings; this does not establish that this product reproduces a trial regimen.
Formulation logic100
The contributing ingredients meet the minimum amount threshold and have no missing required partners. No configured ingredient conflict was identified.
Partner coverage
The contributing ingredients do not require a missing partner in the supplied findings.
Conflicts
No configured ingredient conflict was found in the supplied facts.
Effective doses
All contributing ingredients meet the comparison's minimum amount threshold; this is not proof that one serving produces a clinical effect.
Impact
High effect
Coenzyme Q-10 · 100 mg
Coenzyme Q-10 helps mitochondria transfer electrons during normal cellular energy production. That role does not establish a faster whole-body metabolic rate in adults with adequate nutrition. The supplied studies concern metabolic markers rather than a demonstrated routine increase in energy expenditure, so the declared amount does not establish a metabolism boost.
How this product is rated for Metabolism Support
Ingredient fit73
Coenzyme Q-10 account for the main included ingredient findings. Amount comparisons remain separate from demonstrated increases in energy expenditure.
Goal fit
The included ingredients account for the formula's main connection to the goal, although the product is also linked to other health aims.
Dose adequacy
The included amount provides a partial match to the saved comparison anchor, without establishing a metabolic-rate effect.
Pathways17
The strongest recorded connection concerns mitochondrial energy processing; this does not establish increased whole-body energy expenditure.
Depth
The strongest recorded connection concerns mitochondrial energy processing; this does not establish increased whole-body energy expenditure.
Breadth
None of the tracked mechanisms reaches the breadth criterion; normal nutrient functions alone do not establish broad thermogenic action.
Evidence75
Coenzyme Q-10 leads the finding, although mitochondrial and metabolic-marker evidence does not establish routine thermogenesis.
Evidence strength
Coenzyme Q-10 leads the finding, although mitochondrial and metabolic-marker evidence does not establish routine thermogenesis.
Studied preparation
The included ingredients meet the saved preparation criterion; this does not extend their evidence to a persistent metabolic-rate increase.
Formulation logic100
No required partner is missing and no configured conflict was matched. The amount findings do not establish added thermogenic benefit from the formula.
Partner coverage
The included ingredients have their required partners or can contribute independently; no additional thermogenic benefit from combining them is established.
Conflicts
No configured ingredient conflict was matched in the saved findings.
Effective doses
The included ingredients meet the minimum amount criterion; meeting it does not establish a proven thermogenic dose.
Impact
High effect
Coenzyme Q-10 · 100 mg
Ubiquinone CoQ10 has limited relevance to inflammatory markers from a small trial in statin-treated coronary artery disease. TNF-alpha changed, while endpoint CRP and IL-6 did not. This narrow finding does not establish routine clinical anti-inflammatory benefit, and a label serving does not establish the repeated daily study regimen.
How this product is rated for Inflammation
Ingredient fit66
Coenzyme Q-10 provides the main relevant connection. The amount findings are partial rather than a confirmed clinical dose.
Goal fit
Coenzyme Q-10 supplies the main relevant ingredient connection.
Dose adequacy
Known eligible amounts receive partial comparison recognition; unresolved amounts cannot establish an additional dose contribution.
Pathways13
The strongest retained connection concerns oxidative and mitochondrial stress; this identifies a pathway link rather than proven clinical relief.
Depth
The strongest retained connection concerns oxidative and mitochondrial stress; this identifies a pathway link rather than proven clinical relief.
Breadth
No pathway reaches the saved coverage threshold.
Evidence93
Coenzyme Q-10 provides the strongest retained evidence connection, with limited or inconsistent human outcome findings.
Evidence strength
Coenzyme Q-10 provides the strongest retained evidence connection, with limited or inconsistent human outcome findings.
Studied preparation
Eligible material meets the saved preparation criteria; this does not establish clinical benefit from the exact product.
Formulation logic100
No unmet required partner or configured conflict was identified. Meeting amount criteria does not establish added benefit from combining ingredients.
Partner coverage
No unmet required partner was identified for the retained ingredients; their combination does not establish extra benefit.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
Eligible ingredients meet the saved amount threshold; this is not proof of an effective treatment dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Coenzyme Q-10 (Ubiquinone) | 100 mg |
Coenzyme Q-10 (Ubiquinone) · 100 mg OverallScore72
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
- Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
- The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
- [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
- Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
- Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
- Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
- Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Antifatigue effects of coenzyme Q10 during physical fatigue.
- Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
- Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
- Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
- Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
- The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
- The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
- Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
- Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
- Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
- Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.